Podcast
This month, we spoke with expert Adi Zuloff-Shani, PhD, CEO of Clearmind Medicine.
This month, we spoke with expert Adi Zuloff-Shani, PhD, CEO of Clearmind Medicine, to hear about the new frontier of mental health treatments: psychedelic medicines. Clearmind is developing a novel treatment for addiction, which Zuloff-Shani said is part of a larger shift in approaches to mental health treatments.
Interested in learning more? Check out this related content:
FDA Approves Eladocagene Exuparvovec-Tneq for Treatment of AADC Deficiency